People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Context Therapeutics Inc. | — | Pharmaceuticals | Series C | $100.0M | $923.0M | 2024 |
Jennifer Albert Minai-Azary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jennifer Albert Minai-Azary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alex Albert Levit | 1 | 1 |
| Linda Beth West | 1 | 1 |
| Martin Albert Lehr | 1 | 1 |
| Richard Jay Berman | 1 | 1 |
| Philip Jay Kantoff | 1 | 1 |
| Jennifer Beth Evans Stacey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.